Assessing the impact of the COVID-19 pandemic on uptake and experiences of gestational diabetes mellitus screening in Ontario: A parallel convergent mixed-methods study.

Objective: Gestational diabetes mellitus (GDM) is a common medical complication of pregnancy that leads to adverse outcomes for both infants and pregnant people. Early detection and treatment can mitigate these negative outcomes. The COVID-19 pandemic strained healthcare and laboratory services, including GDM screening programs.

Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort.

Trigeminal neuralgia (TN) is commonly associated with multiple sclerosis (MS). Whether TN should be considered a clinical relapse or evidence of active disease lacks consensus. TN was diagnosed in 0.

User and staff experiences of a revised process for coordinating support with shared decision making in the comorbidity field of practice: a qualitative interview study.

Purpose: This study aims to explore user and staff experiences of a revised process for coordinated individual planning (CIP) that involves the user alongside staff from social services and healthcare and incorporates shared decision-making (SDM).

Method: Eight staff members and five users participated in individual semi-structured interviews. The collected data were analysed using reflexive thematic analysis.

Next-generation Sequencing Improves The Detection of Malignant Biliary Strictures and Changes Management.

Background And Aims: Malignant biliary strictures (MBS) pose diagnostic and therapeutic challenges due to the frequent indeterminate results after initial sampling. Next generation sequencing (NGS) panel (BiliSeq) offers promise in MBS detection, but real-world performance remains uncertain. This study aimed to assess standard sampling techniques alone and with BiliSeq for malignancy detection in biliary strictures, and to evaluate management changes based on NGS.

Identification of potent HSV antivirals using 3D bioprinted human skin equivalents.

Unlabelled: Herpes simplex virus (HSV) infection has worldwide public health concerns and lifelong medical impacts. The standard therapy, acyclovir, has limited efficacy in preventing HSV subclinical virus shedding, and drug resistance occurs in immunocompromised patients, highlighting the need for novel therapeutics. HSV infection manifests in the skin epidermal layer, but current drug discovery utilizes Vero cells and fibroblasts monolayer cultures, capturing neither relevance nor tissue environment.